For CVS Health Corporation [CVS], Analyst sees a rise to $120. What next?

CVS Health Corporation [NYSE: CVS] traded at a low on 08/17/22, posting a -1.42 loss after which it closed the day’ session at $104.92. The company report on August 16, 2022 that Flu shots now available at CVS Pharmacy® and MinuteClinic® nationwide.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


43 percent of Americans say they’ll visit a retail pharmacy to get the flu vaccine this season.

CVS.com and the CVS Pharmacy app allow families to schedule multiple appointments at once, providing added convenience.

The results of the trading session contributed to over 3857376 shares changing hands. Over the past one week, the price volatility of CVS Health Corporation stands at 1.60% while the volatility over the past one month is 1.77%.

The market cap for CVS stock reached $134.97 billion, with 1.31 billion shares outstanding and 1.31 billion shares in the current float. Compared to the average trading volume of 4.92M shares, CVS reached a trading volume of 3857376 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about CVS Health Corporation [CVS]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $119.02 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Loop Capital have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 17, 2022. While these analysts kept the previous recommendation, Bernstein dropped their target price from $122 to $112. The new note on the price target was released on May 27, 2022, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another raise to $110, while Deutsche Bank analysts kept a Hold rating on CVS stock.

The Average True Range (ATR) for CVS Health Corporation is set at 2.03, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.44. The Price to Book ratio for the last quarter was 1.83, with the Price to Cash per share for the same quarter was set at 11.65. Price to Free Cash Flow for CVS in the course of the last twelve months was 10.31 with Quick ratio for the last quarter at 0.70.

How has CVS stock performed recently?

CVS Health Corporation [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.84. With this latest performance, CVS shares gained by 8.40% in over the last four-week period, additionally plugging by 1.89% over the last 6 months – not to mention a rise of 21.34% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 68.53, with the RSI for the last a single of trading hit 69.50, and the three-weeks RSI is set at 65.27 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 95.89, while it was recorded at 105.65 for the last single week of trading, and 99.53 for the last 200 days.

CVS Health Corporation [CVS]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.12 and a Gross Margin at +17.77. CVS Health Corporation’s Net Margin is presently recorded at +2.71.

Return on Equity for this stock inclined to 10.95, with Return on Assets sitting at 3.30.

CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.90.

Earnings analysis for CVS Health Corporation [CVS]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 5.81%.

Insider trade positions for CVS Health Corporation [CVS]

There are presently around $108,540 million, or 80.10% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 114,208,329, which is approximately 2.094% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 94,478,091 shares of the stock with an approximate value of $9.91 billion in CVS stocks shares; and CAPITAL WORLD INVESTORS, currently with $6.17 billion in CVS stock with ownership of nearly 0.346% of the company’s market capitalization.

Positions in CVS Health Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 1,054 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 56,076,221 shares. Additionally, 1,149 investors decreased positions by around 47,829,880 shares, while 260 investors held positions by with 930,598,791 shares. The mentioned changes placed institutional holdings at 1,034,504,892 shares, according to the latest SEC report filing. CVS stock had 109 new institutional investments in for a total of 6,176,409 shares, while 144 institutional investors sold positions of 4,030,941 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here